The EASL guidelines recommend that patients with an ALT of 41–80 U/L should be evaluated for liver histology via transient elastography and/or liver biopsy and antiviral therapy should be contemplated for patients over 30 years old, even if liver fibrosis is not assessed [4]. This evidence concerns the gene GPT and Hepatic fibrosis.